<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="102384">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01737060</url>
  </required_header>
  <id_info>
    <org_study_id>RTSA s422</org_study_id>
    <nct_id>NCT01737060</nct_id>
  </id_info>
  <brief_title>Displaced Proximal Humeral Fractures: Delta Prothesis or Philos Plate?</brief_title>
  <acronym>DELPHI</acronym>
  <official_title>Clinical Investigation for Fractures of the Proximal Humerus in Elderly Patients. A Randomized Study of Two Surgical Treatments: Reverse Total Shoulder Arthroplasty Versus Angular Stable Device Philos</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Oslo University Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Sykehuset Telemark</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Sykehuset Asker og Baerum</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Sykehuset Ostfold</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Helse Førde</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Sykehuset i Vestfold HF</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Oslo University Hospital</source>
  <oversight_info>
    <authority>National Committee for Medical and Health Research Ethics Norway:</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      To investigate the assumption that reversed shoulder prosthetic replacement will give a
      better functional outcome compared to open reduction and internal fixation with an angular
      stable plate in displaced proximal humeral fractures.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      RTSA means Delta Xtend prosthesis. Angular stable plate means Proximal humerus plate
      (Philos)
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>January 2013</start_date>
  <completion_date type="Anticipated">August 2020</completion_date>
  <primary_completion_date type="Anticipated">August 2015</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Outcomes Assessor), Primary Purpose: Treatment</study_design>
  <primary_outcome>
    <measure>Constant Shoulder Score</measure>
    <time_frame>5 years</time_frame>
    <safety_issue>Yes</safety_issue>
    <description>Follow-up will be at 3-6-12 months and 2-5 years.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Oxford Shoulder score</measure>
    <time_frame>5 years</time_frame>
    <safety_issue>No</safety_issue>
    <description>Follow-up will be at 3-6-12 months and 2-5 years.</description>
  </secondary_outcome>
  <other_outcome>
    <measure>15D Quality of Life score</measure>
    <time_frame>5 years</time_frame>
    <safety_issue>No</safety_issue>
    <description>Follow-up will be at 3-6-12 months and 2-5 years.</description>
  </other_outcome>
  <other_outcome>
    <measure>Health Economics</measure>
    <time_frame>5 years</time_frame>
    <safety_issue>No</safety_issue>
    <description>Follow-up will be at 3-6-12 months and 2-5 years.</description>
  </other_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">120</enrollment>
  <condition>Proximal Humeral Fractures of Severe Displaced Types: AO / OTA Group B2 and C2 (Neer 3- and 4 Parts Displaced Fractures)</condition>
  <condition>PMID:18277234</condition>
  <arm_group>
    <arm_group_label>Angular stable plate fixation</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Open Reduction and Osteofixation with Philos plate and TiCron cerclages</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Reverse Total Shoulder Artroplasty</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Intervention group</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Reverse  total shoulder arthroplasty</intervention_name>
    <arm_group_label>Angular stable plate fixation</arm_group_label>
    <arm_group_label>Reverse Total Shoulder Artroplasty</arm_group_label>
    <other_name>Delta Xtend shoulder proshesis</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

        Patient admitted in hospital with a displaced three- or four part proximal humerus
        fracture of OTA / AO group 11-B2 or 11-C2 (displaced fracture of extra-articular or
        articular, bifocal type). The subgroups -.1, -.2 and -.3 will be included for both B2 and
        C2 groups, provided severe displacement: This is defined as a mal-position of at least 45º
        of angular deviation in valgus or 30º in varus in true frontal projection, regardless of
        whether the fracture is impacted or not, or less than 50% contact between humeral head and
        the metaphyseal part of the shaft. The greater or lesser tubercle displaced at least 10
        mm.

        Exclusion Criteria:

        Patient younger than 65 years or older than 85 years, previous history of injury or
        illness of the injured shoulder, injuries of other parts of the humerus or the
        contra-lateral upper extremity, alcohol- or drug abuse, dementia, neurological diseases,
        or severe cardiovascular or lung diseases that would contraindicate surgery. Patients have
        to understand the Norwegian language and be compliant to rehabilitation and follow-ups.
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>65 Years</minimum_age>
    <maximum_age>85 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Tore Fjalestad, MD, PhD.</last_name>
    <phone>0047 22118080</phone>
    <email>tofjal@ous-hf.no</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Jan Erik Madsen, MD, PhD, Professor</last_name>
    <phone>0047 22118080</phone>
    <email>j.e.madsen@klinmed.uio.no</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Oslo University Hospital</name>
      <address>
        <city>Oslo</city>
        <country>Norway</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Tore Fjalestad, MD, PhD</last_name>
      <phone>0047 22118080</phone>
      <email>tofjal@ous-hf.no</email>
    </contact>
    <investigator>
      <last_name>Tore Fjalestad, MD, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Norway</country>
  </location_countries>
  <link>
    <url>http://www.oslo-universitetssykehus.no/fagfolk/forskning/kliniske-studier/Sider/startside.aspx</url>
    <description>There will be a final link before recruiting starts in January 2013</description>
  </link>
  <reference>
    <citation>Marsh JL, Slongo TF, Agel J, Broderick JS, Creevey W, DeCoster TA, Prokuski L, Sirkin MS, Ziran B, Henley B, Audigé L. Fracture and dislocation classification compendium - 2007: Orthopaedic Trauma Association classification, database and outcomes committee. J Orthop Trauma. 2007 Nov-Dec;21(10 Suppl):S1-133.</citation>
    <PMID>18277234</PMID>
  </reference>
  <verification_date>February 2013</verification_date>
  <lastchanged_date>February 21, 2013</lastchanged_date>
  <firstreceived_date>November 20, 2012</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Oslo University Hospital</investigator_affiliation>
    <investigator_full_name>Tore Fjalestad</investigator_full_name>
    <investigator_title>MD PhD Consultant</investigator_title>
  </responsible_party>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Fractures, Bone</mesh_term>
    <mesh_term>Humeral Fractures</mesh_term>
    <mesh_term>Shoulder Fractures</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
